Secondary Logo

Most Popular Articles

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study

Cohen, Roger B.; Delord, Jean-Pierre; Doi, Toshihiko; More

American Journal of Clinical Oncology. 41(11):1083-1088, November 2018.

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma

Gurka, Marie K.; Kim, Christine; He, Aiwu Ruth; More

American Journal of Clinical Oncology. 40(2):152-157, April 2017.

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab

Meredith, Ruby F.; Torgue, Julien J.; Rozgaja, Tania A.; More

American Journal of Clinical Oncology. 41(7):716-721, July 2018.

Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity

Baumann, Brian C.; Wei, Jenny; Plastaras, John P.; More

American Journal of Clinical Oncology. 41(11):1118-1124, November 2018.

Geographic and Patient Characteristics Associated With Election of Prophylactic Mastectomy in Young Breast Cancer Patients With Early Disease

Franc, Benjamin L.; Copeland, Timothy P.; Thombley, Robert; More

American Journal of Clinical Oncology. 41(11):1037-1042, November 2018.

ACR Appropriateness Criteria® Advanced Stage Endometrial Cancer

Elshaikh, Mohamed A.; Yashar, Catheryn M.; Wolfson, Aaron H.; More

American Journal of Clinical Oncology. 37(4):391-396, August 2014.

Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma

Liu, Yong; Zhao, Guoqi; Xu, Yi; More

American Journal of Clinical Oncology. 41(7):619-625, July 2018.

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Total Body Irradiation (TBI)

Wolden, Suzanne L.; Rabinovitch, Rachel A.; Bittner, Nathan H.J.; More

American Journal of Clinical Oncology. 36(1):97-101, February 2013.

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?

Bryant, Curtis; Mendenhall, Nancy P.; Henderson, Randal H.; More

American Journal of Clinical Oncology. 39(3):261-265, June 2016.

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial

Kotecki, Nuria; Le Cesne, Axel; Tresch-Bruneel, Emmanuelle; More

American Journal of Clinical Oncology. 41(11):1094-1100, November 2018.

Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy

Venetis, Maria K.; MacGeorge, Erina L.; Baptiste, Dadrie F.; More

American Journal of Clinical Oncology. 41(6):519-525, June 2018.

ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer

Willers, Henning; Stinchcombe, Thomas E.; Barriger, R. Bryan; More

American Journal of Clinical Oncology. 38(2):197-205, April 2015.

Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver

Vera-Aguilera, Jesus; Bedikian, Agop Y.; Bassett, Roland L.; More

American Journal of Clinical Oncology. 41(11):1132-1136, November 2018.

ACR Appropriateness Criteria® Radiation Therapy for Small-Cell Lung Cancer

Kong, Feng-Ming (Spring); Lally, Brian E.; Chang, Joe Yujiao; More

American Journal of Clinical Oncology. 36(2):206-213, April 2013.

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT)

Hartford, Alan C.; Galvin, James M.; Beyer, David C.; More

American Journal of Clinical Oncology. 35(6):612-617, December 2012.

ACR Appropriateness Criteria® Definitive Therapy for Early-Stage Cervical Cancer

Small, William Jr; Strauss, Jonathan B.; Jhingran, Anuja; More

American Journal of Clinical Oncology. 35(4):399-405, August 2012.

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study

Burtness, Barbara; Powell, Mark; Catalano, Paul; More

American Journal of Clinical Oncology. 39(4):340-345, August 2016.

ACR Appropriateness Criteria® Early-Stage Non–Small–Cell Lung Cancer

Videtic, Gregory M. M.; Chang, Joe Yujiao; Chetty, Indrin J.; More

American Journal of Clinical Oncology. 37(2):201-207, April 2014.

Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases

Cho, Hyungwoo; Kim, Jeong Eun; Kim, Kyu-pyo; More

American Journal of Clinical Oncology. 39(6):623-629, December 2016.

ACR Appropriateness Criteria® Definitive External Beam Irradiation in Stage T1 and T2 Prostate Cancer

Moran, Brian J.; DeRose, Paul; Hsu, I-Chow Joe; More

American Journal of Clinical Oncology. 34(6):636-647, December 2011.

ACR Appropriateness Criteria® Local-regional Recurrence (LR) and Salvage Surgery: Breast Cancer

Halyard, Michele Y.; Wasif, Nabil; Harris, Eleanor E. R.; More

American Journal of Clinical Oncology. 35(2):178-182, April 2012.

ACR Appropriateness Criteria® Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva

Kidd, Elizabeth; Moore, David; Varia, Mahesh A.; More

American Journal of Clinical Oncology. 36(4):415-422, August 2013.

Cardiopulmonary Aerobic Fitness Assessment During Maximal and Submaximal Exercise Testing in Pediatric Oncology Patients After Chemotherapy

Powell, Adam W.; Nagarajan, Rajaram; Mays, Wayne A.; More

American Journal of Clinical Oncology. 41(11):1058-1061, November 2018.

ACR Appropriateness Criteria® Definitive External-Beam Irradiation in Stage T1 and T2 Prostate Cancer

Nguyen, Paul L.; Aizer, Ayal; Assimos, Dean G.; More

American Journal of Clinical Oncology. 37(3):278-288, June 2014.

ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II

Roberts, Kenneth B.; Younes, Anas; Hodgson, David C.; More

American Journal of Clinical Oncology. 39(4):384-395, August 2016.

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials

Langer, Corey J.; Socinski, Mark A.; Patel, Jyoti D.; More

American Journal of Clinical Oncology. 39(5):441-447, October 2016.

Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System

Kikuchi, Luciana; Oliveira, Claudia P.; Alvares-da-Silva, Mario R.; More

American Journal of Clinical Oncology. 39(5):428-432, October 2016.

Fractionated Stereotactic Body Radiation Therapy in the Treatment of Previously-Irradiated Recurrent Head and Neck Carcinoma: Updated Report of the University of Pittsburgh Experience

Rwigema, Jean-Claude; Heron, Dwight E.; Ferris, Robert L.; More

American Journal of Clinical Oncology. 33(3):286-293, June 2010.

Quality of Life, Muscle Strength, and Fatigue Perception in Patients on Suppressive Therapy With Levothyroxine for Differentiated Thyroid Carcinoma

de Oliveira Chachamovitz, Dhiãnah Santini; dos Santos Vigário, Patrícia; Nogueira Cordeiro, Mônica Fabíola; More

American Journal of Clinical Oncology. 36(4):354-361, August 2013.

The Role of Provider Characteristics in the Selection of Surgery or Radiation for Localized Prostate Cancer and Association With Quality of Care Indicators

Satkunasivam, Raj; Lo, Mary; Stern, Mariana; More

American Journal of Clinical Oncology. 41(11):1076-1082, November 2018.

Optimal Equations for Describing the Relationship Between Prostate Volume, Number of Sources, and Total Activity in Permanent Prostate Brachytherapy

Aronowitz, Jesse N.; Michalski, Jeff M.; Merrick, Gregory S.; More

American Journal of Clinical Oncology. 33(2):164-167, April 2010.

A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma

Meyer, Jeffrey; Arriaga, Yull; Anandam, Joselin; More

American Journal of Clinical Oncology. 41(10):972-976, October 2018.

Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer

Wo, Jennifer Y.; Niemierko, Andrzej; Ryan, David P.; More

American Journal of Clinical Oncology. 41(7):656-661, July 2018.

Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study

Albuquerque, Kevin; Folkert, Michael; Mayadev, Jyoti; More

American Journal of Clinical Oncology. 41(8):792-796, August 2018.

COX-2 and NF-KB Overexpression Is Common in Pancreatic Cancer but Does Not Predict for COX-2 Inhibitors Activity in Combination With Gemcitabine and Oxaliplatin

Cascinu, Stefano; Scartozzi, Mario; Carbonari, Giovanna; More

American Journal of Clinical Oncology. 30(5):526-530, October 2007.

Show: